Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p۳۸ MAP Kinase
- سال انتشار: 1391
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 15، شماره: 4
- کد COI اختصاصی: JR_IJBMS-15-4_007
- زبان مقاله: انگلیسی
- تعداد مشاهده: 203
نویسندگان
Pharmaceutical Sciences Research Centre, Mashhad University of Medical sciences Mashhad, Iran
Biotechnology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
Medical Toxicology Research Centre, Mashhad University of Medical Sciences Mashhad, Iran
School of Pharmacy, Mashhad University of Medical Sciences Mashhad, Iran
School of Pharmacy, Mashhad University of Medical Sciences Mashhad, Iran
چکیده
Objective(s) Inhibitors of p۳۸ MAP kinase are considered as suitable target in the treatment of inflammatory diseases such as rheumatoid arthritis and bowel inflammatory diseases. The development of ۵-alkylthio-۱-aryl-۲-(۴-pyridinyl) triazoles as inhibitors of p۳۸ MAP kinase is described. These are analogues of ۴- pyridinyl imidazole p۳۸ MAP kinase inhibitor reported by Merck Research Laboratories, in which imidazole ring has been replaced with triazole. Materials and Methods Reaction of pyridine-۴-carboxylic acid hydrazide ۱ and arylisothiocyanate (۲a, b) gave the intermediate thiourea derivative ۳a, b (Figure ۲). Refluxing of the latter in aqueous saturated sodium carbonate gave ۱-aryl-۵-mercapto-۲-(۴-pyridinyl) triazoles ۴a, b. Treatment of ۴a, b with alkyl iodide afforded the desired ۵-alkylthio-۱-aryl-۲-(۴-pyridinyl) triazoles (۵a-d). P۳۸ MAP kinase inhibitory activity of the synthesized compounds was evaluated in vitro by ELISA method and also by molecular docking. Results Compound ۵c at ۱ µM concentration and compound ۵d at ۱ µM and ۱۰ µM significantly inhibited the p۳۸ phosphorylation. These inhibitory effects are equal to those of standard compound SB۲۰۲۱۹۰ and no significant differences were observed. Conclusion We demonstrated that both tested compounds have inhibitory effect on p۳۸ MAP kinase and we did not find significant difference between their inhibitory effects and those of standard inhibitor SB۲۰۲۱۹۰.کلیدواژه ها
Inhibitors, p۳۸ MAP kinase, Pyridinylimidazolesاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.